Related Experiment Video
Updated: Feb 25, 2026
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Hypoxia associated biomarkers in lung cancer - an update
1Cancer Biomarkers, Therapeutics and Theranostics Laboratory, Tsinghua-Berkeley Shenzhen Institute, Tsinghua University, Shenzhen, China. mppphf@163.com.
Abstract:
The high incidence rates of lung cancer have resulted in multiple progressions in cancer research leading to the development of novel therapeutic strategies. The three main branches of cancer research where improvements are being made are surgery, chemotherapy, and radiotherapy. These research developments have significantly improved the survival rates of cancer patients as most of these therapeutic options target specific molecules involved in cancer progression and metastasis. Experimental research has successfully identified potentially important molecules responsible for cancer progression. Further, the above molecular markers of disease are clinically approved biomolecules of significant prognostic value. The above molecular biomolecules also helped in rapid identification of subgroups of patients who need immediate emergency treatment. Hypoxia is one of such conditions where the human system is deprived of an adequate oxygen supply and requires immediate treatment. Hypoxia markers have been proved to be beneficial in the timely management of cancer. The present review is focused on the latest updates in the area of hypoxia related to markers in the prognosis of lung cancer.
Insights
Lung cancer research advances treatments like surgery and chemotherapy. This review focuses on hypoxia markers for improved lung cancer prognosis and patient management.
Area of Science:
- Oncology
- Molecular Biology
Background:
- High lung cancer incidence drives research into novel therapeutic strategies.
- Improvements in surgery, chemotherapy, and radiotherapy have enhanced patient survival rates.
- Targeting specific molecules in cancer progression and metastasis is key to current research.
Purpose of the Study:
- To review the latest updates on hypoxia markers in lung cancer prognosis.
- To highlight the role of molecular markers in identifying patient subgroups needing urgent treatment.
- To discuss the clinical significance of hypoxia in cancer management.
Main Methods:
- Literature review of experimental research and clinical studies on lung cancer.
- Analysis of molecular markers and their prognostic value.
- Focus on hypoxia and its associated markers in lung cancer.
Main Results:
- Experimental research has identified key molecules in cancer progression.
- Molecular markers offer significant prognostic value and aid in rapid patient subgroup identification.
- Hypoxia markers are beneficial for timely cancer management.
Conclusions:
- Advances in cancer research have led to improved therapeutic strategies for lung cancer.
- Hypoxia is a critical condition requiring immediate treatment, and its markers aid in cancer management.
- Hypoxia markers are crucial for the prognosis and timely intervention in lung cancer cases.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:23Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
02:39lncRNA - Long Non-coding RNAs
01:24Regulation of Angiogenesis and Blood Supply